As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...